Please login to the form below

Regional campaigns: Improving local uptake while staying on-message

Senior Account Manager Dolan Desai talks us through the five core considerations that will allow you to maximise your campaign's impact across a region through coherent execution.
At Blue Latitude Health, our strategic planning, customer experience, and creative services teams work together to ensure that our clients’ campaigns launch without a hitch. We work across many different therapy areas, helping brands to position, launch, and support their campaigns at global, regional, and local levels.

Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated. A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact.

1.  First and foremost, pin down your messaging

Before worrying about country-level assets, you must be crystal clear on what you want those assets to say. Not taking the time to establish and support the regional messaging before rolling out locally can lead to unfocussed and disjointed local activity.

Once your messaging is clear, meaning you know what you want to say, and to whom, then you’re ready to move on to the next step: the messaging framework.

Download the full article and the messaging framework templates in PDF


2nd November 2015

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health